XML 21 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated statements of changes in equity - USD ($)
$ in Thousands
Share capital
Common share
IPO
Share capital
Common share
Over-Allotment Option
Share capital
Common share
Share premium
Series A Preference Shares
Share premium
Series B Preference Shares
Share premium
Series C Preference Shares
Equity-settled employee benefits reserve
Foreign currency translation reserve
Additional paid-in capital
Common share
IPO
Additional paid-in capital
Over-Allotment Option
Additional paid-in capital
Accumulated deficit
Series A Preference Shares
Series B Preference Shares
Series C Preference Shares
Common share
IPO
Over-Allotment Option
Total
Beginning Balance at Dec. 31, 2019       $ 1,221 $ 18,340   $ 365 $ (378)       $ (13,704)           $ 5,844
Beginning Balance (in shares) at Dec. 31, 2019     447,525                   1,755,845 3,899,766        
Loss for period                       (15,927)           (15,927)
Issuance of stock           $ 22,026                       22,026
Issuance of stock (in shares)                             4,133,805      
Series A Preferred and common shares repurchase       (499)               (4,176)           (4,675)
Series A Preferred and common shares repurchase (in shares)     (165,750)                   (718,250)          
Share-based compensation expense             557                     557
Foreign currency translation adjustment               (203)                   (203)
Ending balance at Dec. 31, 2020       722 18,340 22,026 922 (581)       (33,807)           7,622
Ending balance (in shares) at Dec. 31, 2020     281,775                   1,037,595 3,899,766 4,133,805      
Loss for period                       (42,355)           (42,355)
Share split     $ 1,308 (143) (536) (589)         $ (40)              
Issuance of stock $ 947 $ 61 1,425     60,373     $ 87,779 $ 5,877           $ 88,726 $ 5,939 61,798
Issuance of stock (in shares) 6,700,000 425,712                         9,945,221      
Series A Preferred and common shares repurchase     $ (122) (400)             (4,760)             (5,282)
Series A Preferred and common shares repurchase (in shares)     (165,750)                   (718,250)          
Conversion of preference shares       $ (179) $ (17,804) $ (81,810)         99,793              
Conversion of preference shares (in shares)     18,298,137                   (319,345) (3,899,766) (14,079,026)      
Issuance of VUmc common stock     $ 34               3,621             $ 3,655
Issuance of VUmc common stock (in shares)     235,664                             235,664
Share-based compensation expense             3,907                     $ 3,907
Foreign currency translation adjustment               (5,642)                   (5,642)
Ending balance at Dec. 31, 2021     $ 3,653       4,829 (6,223)     192,270 (76,162)           118,367
Ending balance (in shares) at Dec. 31, 2021     25,775,538                              
Loss for period                       (31,907)           (31,907)
Option exercises     $ 3               12             $ 15
Option exercises (in shares)     22,197                             22,197
Issuance of VUmc common stock     $ 59               2,142             $ 2,201
Issuance of VUmc common stock (in shares)     491,352                             491,352
Share-based compensation expense             4,113                     $ 4,113
Foreign currency translation adjustment               (6,749)                   (6,749)
Ending balance at Dec. 31, 2022     $ 3,715       $ 8,942 $ (12,972)     $ 194,424 $ (108,069)           $ 86,040
Ending balance (in shares) at Dec. 31, 2022     26,289,087